Compare BDSX & AIRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDSX | AIRS |
|---|---|---|
| Founded | 2005 | 2012 |
| Country | United States | United States |
| Employees | 334 | 363 |
| Industry | Precision Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 143.2M | 328.7M |
| IPO Year | 2020 | 2021 |
| Metric | BDSX | AIRS |
|---|---|---|
| Price | $14.50 | $4.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $32.50 | N/A |
| AVG Volume (30 Days) | 73.0K | ★ 1.5M |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $88,499,000.00 | ★ $151,818,000.00 |
| Revenue This Year | $25.26 | $5.19 |
| Revenue Next Year | $19.15 | $5.32 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 24.08 | N/A |
| 52 Week Low | $0.26 | $1.51 |
| 52 Week High | $20.21 | $12.00 |
| Indicator | BDSX | AIRS |
|---|---|---|
| Relative Strength Index (RSI) | 53.09 | 77.17 |
| Support Level | $12.77 | $2.40 |
| Resistance Level | $16.26 | $6.90 |
| Average True Range (ATR) | 1.20 | 0.44 |
| MACD | 0.24 | 0.16 |
| Stochastic Oscillator | 67.46 | 93.90 |
Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.